(Q43936457)

English

Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide.

scientific article published in April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamide (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

Coagulation factor VIII

0 references

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

André J Vlot

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Shulamiet Wittebol

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Paul F W Strengers

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Ellen A M Turenhout

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Marijke van den Berg

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Eveline P Mauser-Bunschoten

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

136-140

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11918545%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03383.X

21 January 2018

The hemophilias--from royal genes to gene therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03383.X

21 January 2018

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03383.X

21 January 2018

Intracellular accumulation of factor VIII induced by missense mutations Arg593-->Cys and Asn618-->Ser explains cross-reacting material-reduced haemophilia A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03383.X

21 January 2018

Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03383.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43936457&oldid=2104506753"